blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4355847

EP4355847 - A UNIT DOSE TABLET COMPOSITION [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  22.03.2024
Database last updated on 14.06.2024
FormerThe international publication has been made
Status updated on  23.12.2022
Formerunknown
Status updated on  28.06.2022
Most recent event   Tooltip02.04.2024New entry: Renewal fee paid 
Applicant(s)For:AL  AT  BE  BG  CH  CZ  DK  EE  ES  FI  FR  GR  HR  HU  IS  LI  LT  LU  LV  MC  MK  NL  NO  PL  PT  RO  SE  SI  SK  SM 
Unilever IP Holdings B.V.
Weena 455
3013 AL Rotterdam / NL
For:CY  DE  GB  IE  IT  MT  RS  TR 
Unilever Global IP Limited
Port Sunlight
Wirral, Merseyside CH62 4ZD / GB
[2024/17]
Inventor(s)01 / MURALIDHARAN, Girish
6708 WH Wageningen / NL
02 / RAMACHANDRAN, Rajeesh, Kumar
6708 WH Wageningen / NL
 [2024/17]
Representative(s)Newbould, Frazer Anthony
Unilever Patent Group
Bronland 14
6708 WH Wageningen / NL
[2024/17]
Application number, filing date22731591.801.06.2022
[2024/17]
WO2022EP64898
Priority number, dateEP2021017948815.06.2021         Original published format: EP 21179488
[2024/17]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2022263172
Date:22.12.2022
Language:EN
[2022/51]
Type: A1 Application with search report 
No.:EP4355847
Date:24.04.2024
Language:EN
The application published by WIPO in one of the EPO official languages on 22.12.2022 takes the place of the publication of the European patent application.
[2024/17]
Search report(s)International search report - published on:EP22.12.2022
ClassificationIPC:C11D3/04, C11D3/10, C11D3/00, C11D3/22, C11D3/37, C11D3/12, C11D1/04
[2024/17]
CPC:
C11D3/046 (EP); C11D3/0052 (EP); C11D3/10 (EP);
C11D3/1246 (EP); C11D3/222 (EP); C11D3/226 (EP);
C11D3/3707 (EP); C11D3/3776 (EP); C11D1/04 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2024/17]
Extension statesBANot yet paid
MENot yet paid
Validation statesKHNot yet paid
MANot yet paid
MDNot yet paid
TNNot yet paid
TitleGerman:EINZELDOSISTABLETTENZUSAMMENSETZUNG[2024/17]
English:A UNIT DOSE TABLET COMPOSITION[2024/17]
French:COMPOSITION EN COMPRIMÉ MONODOSE[2024/17]
Entry into regional phase27.11.2023National basic fee paid 
27.11.2023Designation fee(s) paid 
27.11.2023Examination fee paid 
Examination procedure27.11.2023Examination requested  [2024/17]
27.11.2023Date on which the examining division has become responsible
Fees paidRenewal fee
31.03.2024Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]EP0799886  (CLEANTABS AS [DK]) [A] 1-12 * claim - * * composition CL 7;; example 1 * * page 7, line 55 - page 8, line 9 *;
 [AD]WO0043488  (PROCTER & GAMBLE [US], et al) [AD] 1-12 * claim - * * example - * * page 2, line 23 - page 4, line 6 *;
 [A]WO0112767  (PROCTER & GAMBLE [US], et al) [A] 1-12 * claim - * * example - * * page 3, paragraph 2 - page 8, paragraph 2 *;
 [I]US2002028757  (ESPOSITO ANDREA [IT], et al) [I] 1-12 * claim - * * examples IV,IX * * page 16, paragraph 291 - page 17, paragraph 297 * * page 2, paragraph 34 - page 3, paragraph 59 * * page 20, paragraph 353 * * page 21, paragraph 361 * * page 18, paragraph 329 *;
 [A]WO0224848  (RECKITT BENCKISER INC [US], et al) [A] 1-12 * claim - * * example - *;
 [A]GB2375543  (RECKITT BENCKISER INC [US]) [A] 1-12 * claim - * * example - * * page 6, line 9 - page 7, line 21 * * page 9, line 25 - page 11, line l * * page 14, line 14 - line l *;
 [I]US2018105766  (CAPARRÓS CASCO JORDI [ES]) [I] 1-12 * claim - * * example - * * page 5, paragraph 101 - paragraph 109 *;
 [A]  - MOHANACHANDRAN P S ET AL, "Superdisintegrants: An overview", INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES REVIEW AND RESEARCH, GLOBAL RESEARCH ONLINE PUBLISHING HOUSE, IN, (20110101), vol. 6, no. 1, ISSN 0976-044X, pages 105 - 109, XP002755784 [A] 1-12 * the whole document *
by applicantUS4013581
 GB2339575
 DE19843938
 WO0043488
 US2002155976
 US2008135062
    - SCHWARTZPERRY, Surface Active Agents, Interscience, (19490000), vol. 1
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.